17675-42-2 Usage
Description
4-AMINO-N-CYCLOHEXYLBENZAMIDE is a chemical compound with the molecular formula C13H17N3O and a molecular weight of 231.29 g/mol. It is a benzamide derivative featuring a cyclohexylamine moiety and an amino group. 4-AMINO-N-CYCLOHEXYLBENZAMIDE has garnered interest due to its potential applications in various fields, including pharmaceuticals, agrochemicals, organic dyes and pigments, and as a building block in chemical synthesis. Additionally, it may possess biological activities and serve as a precursor for the synthesis of other organic compounds.
Uses
Used in Pharmaceutical Industry:
4-AMINO-N-CYCLOHEXYLBENZAMIDE is utilized as an active pharmaceutical ingredient for the development of new drugs. Its unique structure allows it to interact with biological targets, potentially leading to the treatment of various diseases and conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 4-AMINO-N-CYCLOHEXYLBENZAMIDE is employed as a key component in the formulation of pesticides and other crop protection agents. Its properties may contribute to enhanced pest control and improved crop yields.
Used in Dye and Pigment Industry:
4-AMINO-N-CYCLOHEXYLBENZAMIDE serves as a crucial building block in the synthesis of organic dyes and pigments. Its chemical structure enables the creation of a wide range of colors and hues, which can be applied in various industries such as textiles, plastics, and printing inks.
Used in Chemical Synthesis:
As a versatile building block, 4-AMINO-N-CYCLOHEXYLBENZAMIDE is used in the synthesis of other organic compounds. Its cyclohexylamine and amino groups provide opportunities for further chemical reactions, leading to the formation of new molecules with diverse applications.
Used in Research and Development:
4-AMINO-N-CYCLOHEXYLBENZAMIDE is also used as a research compound to explore its potential biological activities. Scientists investigate its interactions with biological systems to uncover possible therapeutic uses or to gain insights into its mode of action.
Check Digit Verification of cas no
The CAS Registry Mumber 17675-42-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,6,7 and 5 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 17675-42:
(7*1)+(6*7)+(5*6)+(4*7)+(3*5)+(2*4)+(1*2)=132
132 % 10 = 2
So 17675-42-2 is a valid CAS Registry Number.
InChI:InChI=1/C13H18N2O/c14-11-8-6-10(7-9-11)13(16)15-12-4-2-1-3-5-12/h6-9,12H,1-5,14H2,(H,15,16)
17675-42-2Relevant articles and documents
Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis
Bao, Xuefei,Chen, Guoliang,Du, Fangyu,Hammock, Bruce D.,Liu, Qiu,Liu, Zhongbo,Morisseau, Christophe,Sun, Wenjiao,Wang, Chao,Xiao, Wei,Yang, Hao,Zhang, Tan,Zhou, Jun
, (2021)
Sepsis, a systemic inflammatory response, caused by pathogenic factors including microorganisms, has high mortality and limited therapeutic approaches. Herein, a new soluble epoxide hydrolase (sEH) inhibitor series comprising a phenyl ring connected to a
sEH inhibitor and preparation method and application thereof
-
Paragraph 0234; 0236; 0239-0240, (2020/07/28)
The invention provides an sEH inhibitor and a preparation method and application thereof, and relates to the technical field of endogenous active substance regulation and control. The sEH inhibitor provided by the invention has a structure as shown in a f
PURINE AND 3-DEAZAPURINE ANALOGUES AS CHOLINE KINASE INHIBITORS
-
Page/Page column 119, (2018/02/28)
There are provided substituted purine and 3-deazapurine analogues, which modulate the activity of Choline Kinase (ChoK). The compounds of this invention are therefore useful in treating diseases caused by an altered choline metabolism, such as cancer, cell proliferative disorders, infectious diseases of different origin, immune-related disorders and neurodegenerative disorders. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing pharmaceutical compositions comprising these compounds.